Sequent Scientific Limited (BOM: 512529)
179.85
+3.85 (2.19%)
At close: Sep 10, 2024
Sequent Scientific Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
Net Income | - | -358.69 | -1,212 | 409.55 | 954.42 | 699.05 | Upgrade
|
Depreciation & Amortization | - | 597.5 | 535.17 | 476.57 | 475.04 | 477.48 | Upgrade
|
Other Amortization | - | 17.9 | 21.76 | 38.84 | 30.94 | 28.74 | Upgrade
|
Loss (Gain) From Sale of Assets | - | -55.42 | -20.42 | 0.69 | -6.98 | -1.14 | Upgrade
|
Asset Writedown & Restructuring Costs | - | 229.78 | 617.56 | 0.34 | 30.69 | - | Upgrade
|
Loss (Gain) From Sale of Investments | - | -0.4 | -0.51 | -3.18 | -25.96 | -7.74 | Upgrade
|
Stock-Based Compensation | - | 222.28 | 354.11 | 333.01 | 72.34 | 46.67 | Upgrade
|
Provision & Write-off of Bad Debts | - | 14.39 | 9.39 | 3.11 | 8.99 | 25.7 | Upgrade
|
Other Operating Activities | - | 95.33 | 378.62 | -61.17 | 316.92 | 467.51 | Upgrade
|
Change in Accounts Receivable | - | -87.82 | -412.64 | -407.24 | -394.75 | -508.17 | Upgrade
|
Change in Inventory | - | 2.86 | 50.79 | -1,147 | -456.17 | -193.14 | Upgrade
|
Change in Accounts Payable | - | -371.36 | -170.13 | 654.65 | 89.29 | 153.13 | Upgrade
|
Change in Other Net Operating Assets | - | -0.4 | 15.85 | 6.95 | 52.77 | -34.79 | Upgrade
|
Operating Cash Flow | - | 305.95 | 168.08 | 305.95 | 1,148 | 1,153 | Upgrade
|
Operating Cash Flow Growth | - | 82.03% | -45.06% | -73.34% | -0.50% | -0.60% | Upgrade
|
Capital Expenditures | - | -308.07 | -861.79 | -324.64 | -528.3 | -407.22 | Upgrade
|
Sale of Property, Plant & Equipment | - | 191.52 | 116.71 | 11.91 | 82.6 | 7.23 | Upgrade
|
Cash Acquisitions | - | - | -154.4 | -684.67 | -1,405 | - | Upgrade
|
Investment in Securities | - | -82.23 | 237.56 | 37.48 | 1,931 | -389.7 | Upgrade
|
Other Investing Activities | - | 79.73 | 12.34 | 4.26 | 16.24 | 66.99 | Upgrade
|
Investing Cash Flow | - | -119.05 | -649.58 | -955.66 | 96.48 | -722.7 | Upgrade
|
Short-Term Debt Issued | - | 584.22 | 557.52 | 549.24 | - | 27.52 | Upgrade
|
Long-Term Debt Issued | - | 548.5 | 575.43 | 674.98 | 879.46 | 852.17 | Upgrade
|
Total Debt Issued | - | 1,133 | 1,133 | 1,224 | 879.46 | 879.69 | Upgrade
|
Short-Term Debt Repaid | - | - | - | - | -435.31 | - | Upgrade
|
Long-Term Debt Repaid | - | -692.89 | -451.94 | -361.86 | -1,695 | -919.89 | Upgrade
|
Total Debt Repaid | - | -692.89 | -451.94 | -361.86 | -2,130 | -919.89 | Upgrade
|
Net Debt Issued (Repaid) | - | 439.83 | 681.01 | 862.36 | -1,250 | -40.2 | Upgrade
|
Issuance of Common Stock | - | 59.85 | - | 21.16 | 104.49 | 20.99 | Upgrade
|
Common Dividends Paid | - | - | - | -123.44 | - | -48.56 | Upgrade
|
Other Financing Activities | - | -454.22 | -358.73 | -87.51 | -241.61 | -359.76 | Upgrade
|
Financing Cash Flow | - | 45.46 | 322.28 | 672.57 | -1,388 | -427.53 | Upgrade
|
Miscellaneous Cash Flow Adjustments | - | - | - | 14.66 | - | - | Upgrade
|
Net Cash Flow | - | 232.36 | -159.22 | 37.52 | -143.52 | 3.07 | Upgrade
|
Free Cash Flow | - | -2.12 | -693.71 | -18.69 | 619.24 | 746.08 | Upgrade
|
Free Cash Flow Growth | - | - | - | - | -17.00% | -17.63% | Upgrade
|
Free Cash Flow Margin | - | -0.02% | -4.88% | -0.13% | 4.55% | 6.33% | Upgrade
|
Free Cash Flow Per Share | - | -0.01 | -2.79 | -0.07 | 2.50 | 3.04 | Upgrade
|
Cash Interest Paid | - | 453.46 | 355.71 | 162.12 | 227.5 | 330.52 | Upgrade
|
Cash Income Tax Paid | - | 140.56 | 146.43 | 267.67 | 437.93 | 128.24 | Upgrade
|
Levered Free Cash Flow | - | 401.97 | -565.47 | -5.08 | 742.69 | 468.1 | Upgrade
|
Unlevered Free Cash Flow | - | 692.12 | -379.72 | 79.35 | 863.03 | 672.49 | Upgrade
|
Change in Net Working Capital | - | -17.05 | 333.06 | 806.69 | 302.41 | 255.86 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.